Moelis & Company (MC)
NYSE: MC · IEX Real-Time Price · USD
57.24
+0.10 (0.18%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Company Description

Moelis & Company operates as an investment banking advisory firm.

It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters, as well as strategic, capital structure, and private funds advisory.

The company offers its services to public multinational corporations, middle market private companies, financial sponsors, entrepreneurs, governments, and sovereign wealth funds.

It operates in North and South America, Europe, the Middle East, Asia, and Australia. The company was founded in 2007 and is headquartered in New York, New York.

Moelis & Company
Moelis & Company logo
Country United States
Founded 2007
IPO Date Apr 16, 2014
Industry Capital Markets
Sector Financials
Employees 1,161
CEO Kenneth David Moelis

Contact Details

Address:
399 Park Avenue, 5th Floor
New York, New York 10022
United States
Phone (212) 883-3800
Website moelis.com

Stock Details

Ticker Symbol MC
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001596967
CUSIP Number 60786M105
ISIN Number US60786M1053
Employer ID 46-4500216
SIC Code 6282

Key Executives

Name Position
Kenneth David Moelis Founder, Chief Executive Officer and Director
Elizabeth Ann Crain Co-Founder, Founding Partner and Vice Chair
Eric Cantor Vice Chairman and MD
Navid Mahmoodzadegan Co-Founder, Founding Partner, Co-President and MD
Jeffrey Raich Co-Founder, Co-President and MD
Joseph Walter Simon CPA Chief Financial Officer
Stephen M. Trauber Global Head of Energy and Clean Technology and Chairman
Michele S. Miyakawa Co-Founder and MD of Los Angeles
John Momtazee J.D. Co-Founder, Founding Partner, MD of Los Angeles and Global Head of Media Investment Banking
Kate Pilcher Ciafone Co- Founder and Chief Operating Officer

Latest SEC Filings

Date Type Title
Jun 18, 2024 S-8 Securities to be offered to employees in employee benefit plans
Jun 7, 2024 8-K Current Report
May 13, 2024 144 Filing
May 10, 2024 144 Filing
May 9, 2024 144 Filing
Apr 25, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 25, 2024 DEF 14A Other definitive proxy statements
Apr 25, 2024 10-Q Quarterly Report
Apr 24, 2024 ARS Filing
Apr 24, 2024 8-K Current Report